Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea

Conditions:   Acquired Immunodeficiency Syndrome;   Healthy Volunteers;   HIV/AIDS;   HIV Diarrhea;   Human Immunodeficiency Virus Intervention:   Drug: Crofelemer delayed-release tablets 125mg Sponsor:   Napo Pharmaceuticals, Inc. Recruiting

Source: ClinicalTrials.gov - December 10, 2019 Category: Research Source Type: clinical trials